184 related articles for article (PubMed ID: 22581253)
1. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions.
Kehrer-Sawatzki H; Vogt J; Mußotter T; Kluwe L; Cooper DN; Mautner VF
Neurogenetics; 2012 Aug; 13(3):229-36. PubMed ID: 22581253
[TBL] [Abstract][Full Text] [Related]
2. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H; Mautner VF; Cooper DN
Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
[TBL] [Abstract][Full Text] [Related]
3. High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.
Kehrer-Sawatzki H; Kluwe L; Sandig C; Kohn M; Wimmer K; Krammer U; Peyrl A; Jenne DE; Hansmann I; Mautner VF
Am J Hum Genet; 2004 Sep; 75(3):410-23. PubMed ID: 15257518
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
5. Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports.
Vogt J; Nguyen R; Kluwe L; Schuhmann M; Roehl AC; Mußotter T; Cooper DN; Mautner VF; Kehrer-Sawatzki H
J Med Case Rep; 2011 Dec; 5():577. PubMed ID: 22151963
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature.
Mensink KA; Ketterling RP; Flynn HC; Knudson RA; Lindor NM; Heese BA; Spinner RJ; Babovic-Vuksanovic D
J Med Genet; 2006 Feb; 43(2):e8. PubMed ID: 16467218
[TBL] [Abstract][Full Text] [Related]
7. Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2021 Dec; 140(12):1635-1649. PubMed ID: 34535841
[TBL] [Abstract][Full Text] [Related]
8. Genotype-Phenotype Associations in Patients With Type-1, Type-2, and Atypical
Büki G; Zsigmond A; Czakó M; Szalai R; Antal G; Farkas V; Fekete G; Nagy D; Széll M; Tihanyi M; Melegh B; Hadzsiev K; Bene J
Front Genet; 2021; 12():673025. PubMed ID: 34168676
[TBL] [Abstract][Full Text] [Related]
9. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).
Messiaen L; Vogt J; Bengesser K; Fu C; Mikhail F; Serra E; Garcia-Linares C; Cooper DN; Lazaro C; Kehrer-Sawatzki H
Hum Mutat; 2011 Feb; 32(2):213-9. PubMed ID: 21280148
[TBL] [Abstract][Full Text] [Related]
10. Clinical characterization of children and adolescents with NF1 microdeletions.
Kehrer-Sawatzki H; Kluwe L; Salamon J; Well L; Farschtschi S; Rosenbaum T; Mautner VF
Childs Nerv Syst; 2020 Oct; 36(10):2297-2310. PubMed ID: 32533297
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the entire NF1 gene causing distinct manifestations in a family.
Wu BL; Schneider GH; Korf BR
Am J Med Genet; 1997 Mar; 69(1):98-101. PubMed ID: 9066892
[TBL] [Abstract][Full Text] [Related]
12. Growth in neurofibromatosis 1 microdeletion patients.
Ning X; Farschtschi S; Jones A; Kehrer-Sawatzki H; Mautner VF; Friedman JM
Clin Genet; 2016 Mar; 89(3):351-4. PubMed ID: 26111455
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Mosaicism of a novel nonsense variant in the neurofibromin gene underlies a mosaic generalized NF1 phenotype.
Kwong HL; Tay YK; Tan EC
F1000Res; 2021; 10():148. PubMed ID: 34164111
[TBL] [Abstract][Full Text] [Related]
14. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype.
Pasmant E; Sabbagh A; Spurlock G; Laurendeau I; Grillo E; Hamel MJ; Martin L; Barbarot S; Leheup B; Rodriguez D; Lacombe D; Dollfus H; Pasquier L; Isidor B; Ferkal S; Soulier J; Sanson M; Dieux-Coeslier A; Bièche I; Parfait B; Vidaud M; Wolkenstein P; Upadhyaya M; Vidaud D;
Hum Mutat; 2010 Jun; 31(6):E1506-18. PubMed ID: 20513137
[TBL] [Abstract][Full Text] [Related]
15. Atypical
Kehrer-Sawatzki H; Wahlländer U; Cooper DN; Mautner VF
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681033
[TBL] [Abstract][Full Text] [Related]
16. Do NF1 gene deletions result in a characteristic phenotype?
Tonsgard JH; Yelavarthi KK; Cushner S; Short MP; Lindgren V
Am J Med Genet; 1997 Nov; 73(1):80-6. PubMed ID: 9375928
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1.
Tanito K; Ota A; Kamide R; Nakagawa H; Niimura M
J Dermatol; 2014 Aug; 41(8):724-8. PubMed ID: 25041723
[TBL] [Abstract][Full Text] [Related]
18. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
19. Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata.
Leppig KA; Kaplan P; Viskochil D; Weaver M; Ortenberg J; Stephens K
Am J Med Genet; 1997 Dec; 73(2):197-204. PubMed ID: 9409873
[TBL] [Abstract][Full Text] [Related]
20. Elevated risk for MPNST in NF1 microdeletion patients.
De Raedt T; Brems H; Wolkenstein P; Vidaud D; Pilotti S; Perrone F; Mautner V; Frahm S; Sciot R; Legius E
Am J Hum Genet; 2003 May; 72(5):1288-92. PubMed ID: 12660952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
